Want to see SINT full AI Analyst Report?
SINT Stock Chart & Stats
$3.74
-$0.35(-9.09%)
At close: 4:00 PM EST
$3.74
-$0.35(-9.09%)
Day’s Range― - ―
52-Week Range$1.80 - $6.78
Previous CloseN/A
Volume24.46K
Average Volume (3M)148.79K
Market Cap
$11.89M
Enterprise Value$7.14M
Total Cash (Recent Filing)$1.89M
Total Debt (Recent Filing)$3.26M
Price to Earnings (P/E)―
Beta2.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,357,630
10 Day Avg. Volume107,243
30 Day Avg. Volume148,787
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue6.94
Enterprise Value/Gross Profit-21.26
Enterprise Value/Ebitda-0.70
Forecast
1Y Price Target
$8.00Price Target Upside113.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Silicon Nitride TechnologySintx’s focus on silicon nitride (Si3N4) provides a durable technical moat: the material’s unique bio‑ and mechanical properties support differentiated medical implant applications and potential industrial uses. This specialization underpins long‑term product differentiation and targeted commercialization opportunities.
Recent Capital Raise Improves Near‑Term LiquidityThe ~$4.5M private placement (plus an earlier $0.5M ATM) materially extends runway, funding commercialization, business development, and working capital. Structurally this reduces immediate refinancing pressure and gives management time to advance product commercialization and partnership discussions.
Relatively Modest Absolute Debt LevelsWhile equity has eroded, nominal debt is modest in absolute terms. Lower absolute interest and principal obligations reduce near‑term solvency pressure relative to highly leveraged peers, preserving flexibility to pursue additional financing or strategic partnerships without excessive debt service strain.
Bears Say
Persistent Cash Burn & Negative Gross ProfitSustained operating cash outflows and negative gross profit indicate the business model is not yet generating self‑funding operations. Continued cash burn forces recurring capital raises, dilutes shareholders, and undermines the company’s ability to invest consistently in commercialization and scale without external funding.
Nasdaq Noncompliance And Equity DeficitA reported equity deficit and Nasdaq noncompliance elevate structural listing and financing risk. The need to remediate within prescribed timelines can force dilutive financing or rushed transactions, reduce institutional investor interest, and create execution risk that materially affects long‑term access to capital.
Significant Dilution Risk From Warrants And TermsHeavy warrant coverage, long-dated exercise terms, and full‑ratchet anti‑dilution protections materially increase future dilution risk and complicate capital structure. These features can deter new investors, depress per‑share economics for existing holders, and constrain management’s flexibility to raise non‑dilutive capital.
SINT FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest stock price was $1.80 and its highest was $6.78 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is $11.89M.
When is Sintx Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sintx Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 6,357,630 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in SINT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
SINT Stock 12 Month Forecast
Average Price Target
$8.00
▲(113.90% Upside)
Technical Analysis
Strata Skin Sciences
―
Solana Company
―
Vyome Holdings
―
Co-Diagnostics
―
Tenon Medical, Inc.
―
Ownership Overview
4.20% Insiders
0.72% Mutual Funds
1.71% Other Institutional Investors
92.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---







